D. McMahon

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

J. Tsevat, A. Butt, V. Lo Re, 2009, HIV clinical trials.

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

J. Tsevat, A. Butt, D. McMahon, 2009 .

Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.

J. Hitti, K. Klingman, D. McMahon, 2012, Applied clinical trials.

A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS.

C. Rinaldo, Xiao-li Huang, T. Whiteside, 1993, Blood.

Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus.

A. Leonard, J. Tsevat, A. Butt, 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Anti-Human Immunodeﬁciency Virus Type 1 (HIV-1) CD8 1 T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeﬁciency

J. Margolick, J. Mellors, C. Rinaldo, 2000 .

Isolated right ventricular dysfunction in patients with human immunodeficiency virus.

M. Gladwin, C. Kessinger, M. Simon, 2014, Journal of cardiac failure.

ABCG2 Deficiency Does Not Alter Dolutegravir Metabolism and Pharmacokinetics

Junjie Zhu, Xiaochao Ma, Amina I. Shehu, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation

R. Greenblatt, L. Kingsley, E. Ghedin, 2018, PloS one.

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis

J. Luketich, J. Mellors, D. Angus, 2021, medRxiv.

Long-Term Efﬁcacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor–Naive Adults with Advanced HIV Infection

M. Hirsch, B. Hirschel, R. Leavitt, 2003 .

Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity.

T. Whiteside, J. Armstrong, M. Ho, 1993, Clinical immunology and immunopathology.

Generation and characterization of ex vivo propagated autologous CD8+ cells used for adoptive immunotherapy of patients infected with human immunodeficiency virus

Phalguni Gupta, C. Rinaldo, Xiao-li Huang, 1993 .

Generation and characterization of ex vivo propagated autologous CD8+ cells used for adoptive immunotherapy of patients infected with human immunodeficiency virus.

C. Rinaldo, T. Whiteside, J. Armstrong, 1993, Blood.

Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy.

J. Mellors, F. Maldarelli, D. McMahon, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The north-south divide: Substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities

L. Metsch, D. Feaster, L. Gooden, 2015 .

Reduction of the HIV-1 reservoir in T cells from persons with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells ex vivo

Michele D. Sobolewski, J. Karn, J. Mellors, 2022, bioRxiv.

Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients.

Z. Fan, C. Rinaldo, P. Piazza, 1991, The Journal of infectious diseases.

The effect of age on CD4+ T-cell recovery in HIV-suppressed adult participants: a sub-study from AIDS Clinical Trial Group (ACTG) A5321 and the Bone Loss and Immune Reconstitution (BLIR) study

I. Ofotokun, R. Gandhi, Kristina De Paris, 2022, Immunity & ageing : I & A.

Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?

Rebecca J. Cope, D. McMahon, Ramakrishna Prasad, 2016, AIDS patient care and STDs.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

D. Angus, J. Luketich, M. Schwartz, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

D. Richman, D. Havlir, J. Mellors, 1998, JAMA.

Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

F. Sciurba, S. Wenzel, C. Kessinger, 2010, American journal of respiratory and critical care medicine.

CD4+ T Cell Dysfunction in Severe COVID-19 Disease is TNFα/TNFRI-Dependent.

Bill B. Chen, M. Saul, D. Triulzi, 2022, American journal of respiratory and critical care medicine.

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

R Rode, M Salgo, D. Ho, 1999, AIDS.

Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults

J. Bartlett, J. Mellors, S. Riddler, 1996, Antimicrobial agents and chemotherapy.

A phase I study of ampligen in human immunodeficiency virus-infected subjects.

C. Rinaldo, D. Schoenfeld, J. Armstrong, 1992, The Journal of infectious diseases.

Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.

D. Haas, U. Lalloo, E. Acosta, 2013, The Journal of infectious diseases.

Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.

M. Hughes, J. Mellors, J. Hitti, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

J. Mellors, J. Condra, J. Chodakewitz, 2000, Annals of Internal Medicine.

Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial.

M. Lederman, L. Kalish, S. Assmann, 2001, JAMA.

Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine

K. K. Lai, D. Katzenstein, M. Hirsch, 1995 .

CD4+ T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent

Bill B. Chen, D. Triulzi, D. Kass, 2022, American Journal of Respiratory and Critical Care Medicine.

CD4+ T cell lymphopenia and dysfunction in severe COVID-19 disease is autocrine TNF-α/TNFRI-dependent

Bill B. Chen, M. Saul, J. Pilewski, 2021, bioRxiv.

Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy

E. Rosenberg, M. Lederman, M. Peluso, 2022, Cell host & microbe.

Extragenital Mycoplasma hominis infections in adults.

J. Dummer, G. Cassell, A. Pasculle, 1990, The American journal of medicine.

Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110α That Reactivates Latent HIV-1

J. Mellors, K. Huber, N. Sluis-Cremer, 2014, PloS one.

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

D. Havlir, D. Margolis, K. Robertson, 2007, The Journal of infectious diseases.

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

J. Mellors, S. Holmes, R. Bosch, 2022, Frontiers in Cellular and Infection Microbiology.

Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma

A. Krishnan, J. Mellors, J. Rossi, 2013, Journal of acquired immune deficiency syndromes.

Pregnane X receptor activation potentiates ritonavir hepatotoxicity.

Junjie Zhu, Da Yang, Jie Lu, 2019, The Journal of clinical investigation.

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

J. Mellors, R. Bosch, R. B. Jones, 2021, AIDS.

Decreased Lung Function and All‐Cause Mortality in HIV‐infected Individuals

R. Greenblatt, L. Kingsley, C. Kessinger, 2018, Annals of the American Thoracic Society.

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

J. Mellors, R. Bosch, C. Rinaldo, 2017, PLoS pathogens.

Targeting xenobiotic nuclear receptors PXR and CAR to prevent cobicistat hepatotoxicity.

Junjie Zhu, Jie Lu, F. Gonzalez, 2021, Toxicological sciences : an official journal of the Society of Toxicology.

Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeficiency

J. Margolick, J. Mellors, C. Rinaldo, 2000, Journal of Virology.

HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2021, JCI insight.

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.

J. Siliciano, J. Mellors, R. Bosch, 2020, The Journal of infectious diseases.

Naïve CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-Competent HIV-1.

J. Mellors, N. Sluis-Cremer, D. McMahon, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

J. Mellors, R. Bosch, S. Riddler, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

C. Spina, J. Mellors, Helen Yu, 2014, PLoS pathogens.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

S J Gange, S. Gange, J. Metcalf, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

B. Walker, C. Kovacs, J. Mellors, 2017, PLoS pathogens.

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy

J. Mellors, M. Para, A. Cillo, 2014, PloS one.

Comparison of methods to quantify inducible HIV-1 outgrowth

J. Mellors, J. Eron, R. Gandhi, 2021, Journal of virus eradication.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

C. del Rio, M. Mugavero, L. Metsch, 2016, JAMA.

Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals

R. Greenblatt, L. Kingsley, C. Kessinger, 2018, Journal of acquired immune deficiency syndromes.

Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study

J. Leader, S. Wenzel, C. Kessinger, 2016, BMC Pulmonary Medicine.

Brief Report: Association Between Pain, Pulmonary Function, and Respiratory Symptoms in People With HIV

C. Kessinger, M. Nouraie, A. Morris, 2021, Journal of acquired immune deficiency syndromes.

Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease

S. Wisniewski, L. Kingsley, J. Leader, 2017, AIDS.

Asthma diagnosis and airway bronchodilator response in HIV-infected patients.

F. Sciurba, S. Wenzel, C. Kessinger, 2012, The Journal of allergy and clinical immunology.

HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2020 .

Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.

D. Angus, J. Luketich, M. Schwartz, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

D. Richman, D. Havlir, J. Mellors, 2003, AIDS.

CYP1A1 and 1B1‐mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor

Junjie Zhu, Jie Lu, Feng Li, 2018, Biochemical pharmacology.

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.

J. Mellors, C. Rinaldo, S. Riddler, 1999, The Journal of infectious diseases.

Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy.

J. Becker, J. Mellors, C. Achim, 2002, AIDS research and human retroviruses.

Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial.

J. Mellors, M. Horowitz, U. Popat, 2017 .

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy

R. Siliciano, J. Mellors, R. Bosch, 2019 .

Serum (1→3)-&bgr;-D-Glucan Levels in HIV-Infected Individuals Are Associated With Immunosuppression, Inflammation, and Cardiopulmonary Function

C. Kessinger, M. Finkelman, A. Morris, 2012, Journal of acquired immune deficiency syndromes.

Chest Computed Tomography Findings in HIV-Infected Individuals in the Era of Antiretroviral Therapy

J. Leader, C. Fuhrman, C. Kessinger, 2014, PloS one.

Case of the month. Disseminated histoplasmosis presenting as myositis and fasciitis in a patient with dermatomyositis

D. Lacomis, D. McMahon, D. McMahon, 1995, Muscle & nerve.

Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.

C. Fox, A. Fauci, G. Pantaleo, 1996, The Journal of infectious diseases.

Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era

M. Gladwin, F. Sciurba, C. Kessinger, 2012, AIDS.

No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

J. Mellors, R. Bosch, C. Rinaldo, 2019, Journal of acquired immune deficiency syndromes.

Association Between Inflammatory Pathways and Phenotypes of Pulmonary Dysfunction Using Cluster Analysis in Persons Living With HIV and HIV-Uninfected Individuals.

L. Kingsley, J. Leader, C. Kessinger, 2020, Journal of acquired immune deficiency syndromes.

The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus–Infected Patients in 11 US Cities

C. del Rio, L. Metsch, D. Feaster, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort

M. Bertolet, C. Kessinger, A. Vallejo, 2014, AIDS.

Pulmonary Function In Human Immunodeficiency Virus Infected Individuals

F. Sciurba, C. Kessinger, A. Morris, 2010, ATS 2010.

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy

J. Mellors, R. Bosch, J. Eron, 2022, Journal of virus eradication.

Contributors to diffusion impairment in HIV-infected persons

J. Leader, F. Sciurba, C. Fuhrman, 2013, European Respiratory Journal.

Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207

J. Mellors, U. Lalloo, J. Pape, 2014, Journal of AIDS & clinical research.

A Phase I study of subcutaneous recombinant interleukin‐2 in patients with advanced HIV disease while on zidovudine

Phalguni Gupta, C. Rinaldo, Xiao-li Huang, 1994, AIDS.

Levels Of (1—>3)-ß-D-Glucan In Human Immunodeficiency Virus-Infected Individuals

C. Kessinger, M. Finkelman, A. Morris, 2011, ATS 2011.

Asthma diagnosis and airway bronchodilator response in HIV-infected patients.

F. Sciurba, S. Wenzel, C. Kessinger, 2012, The Journal of allergy and clinical immunology.

A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).

J. Karn, J. Mellors, E. Acosta, 2020, The Journal of infectious diseases.

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

J. Mellors, R. Bosch, R. B. Jones, 2022, AIDS.

Efficacy, Safety, and Tolerability of Long-Term Combination Antiretroviral Therapy in Asymptomatic Treatment-Naïve Adults with Early HIV Infection

A. Meibohm, M. Dinubile, M. Robertson, 2007, HIV clinical trials.